These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6149671)

  • 1. Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial.
    Dahlström U; Areskog M; Wranne B; Karlsson E
    Acta Med Scand; 1984; 216(2):199-207. PubMed ID: 6149671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure (author's transl)].
    Lambertz H; Erbel R; Meyer J; Schweizer P; Effert S
    Z Kardiol; 1982 Jan; 71(2):65-74. PubMed ID: 6122313
    [No Abstract]   [Full Text] [Related]  

  • 3. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
    Glover DR; Wathen CG; Murray RG; Petch MC; Muir AL; Littler WA
    Br Heart J; 1985 Feb; 53(2):208-15. PubMed ID: 2857088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.
    Lambertz H; Meyer J; Erbel R
    Circulation; 1984 Feb; 69(2):298-305. PubMed ID: 6140091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute haemodynamic effects of oral prenalterol in severe heart failure.
    Petch MC; Wisbey C; Ormerod O; Scott C; Goodfellow RM
    Br Heart J; 1984 Jul; 52(1):49-52. PubMed ID: 6146324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
    Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
    Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
    Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
    Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prenalterol administered orally in patients with congestive heart failure.
    Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
    Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
    Hutton I; Tweddel AC; Bastian BC; Murray RG
    Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
    [No Abstract]   [Full Text] [Related]  

  • 10. A dose response study with oral prenalterol in patients with chronic congestive cardiac failure.
    Hendry WG; Comerford MB; Besterman EM
    Clin Cardiol; 1984 Jan; 7(1):23-8. PubMed ID: 6705284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of beta 1 agonism with prenalterol on catecholamine circulating levels in patients with congestive heart failure.
    Corea L; Bentivoglio M; Verdecchia P; Provvidenza M
    G Ital Cardiol; 1983 Nov; 13(11):330-4. PubMed ID: 6141975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
    Currie PJ; Kelly MJ; Middlebrook K; Federman J; Sainsbury E; Ashley J; Pitt A
    Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenalterol in the treatment of congestive heart failure developing during beta-blocking therapy. A comparison with frusemide in patients with acute myocardial infarction.
    Dahlström U; Karlsson E
    Acta Med Scand; 1982; 212(3):125-30. PubMed ID: 6128867
    [No Abstract]   [Full Text] [Related]  

  • 14. The hemodynamic actions of prenalterol in left ventricular failure.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.
    Drexler H; Löllgen H; Just H
    Klin Wochenschr; 1981 Jun; 59(12):647-54. PubMed ID: 7253539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
    Drexler H; Löllgen H; Just H
    Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic therapy of congestive cardiomyopathy: effects of prenalterol and digoxin].
    Schwarz KR; Hofmann M; Mäurer W; Kadel C; von Olshausen K; Rauch B; Kübler W
    Z Kardiol; 1985 Jul; 74(7):374-83. PubMed ID: 3929486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
    Waagstein F; Estrada-Yamamoto M; Reiz S; Reyes C; Hjalmarson A
    Acta Med Scand Suppl; 1982; 659():221-31. PubMed ID: 6127891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Prenalterol on left ventricular function of coronary patients].
    Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
    Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.